BREAKING: Largest Human Cancer Study of Ivermectin + Mebendazole Is Now PEER-REVIEWED and PUBLISHED in a MAJOR Cancer Journal
84.4% of cancer patients taking ivermectin + mebendazole for 6 months declared either CANCER DISAPPEARANCE, TUMOR REGRESSION, or CANCER STABILIZATION.
Our study, “Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort,” is now peer-reviewed and published in Anticancer Research—a major international oncology journal of the International Institute of Anticancer Research (IIAR), established in 1995.
The results represent one of the most compelling clinical signals ever documented for repurposed anti-parasitic therapies in oncology.
A diverse population of cancer patients (n=197) was prescribed compounded ivermectin–mebendazole through a U.S. telemedicine platform, with each capsule containing 25 mg ivermectin and 250 mg mebendazole.
Participants were followed for approximately six months using standardized digital surveys assessing cancer outcomes, medication adherence, and tolerability.
At approximately six months post-treatment initiation, we observed an 84.4% Clinical Benefit Ratio (CBR)—meaning more than four out of five patients reported either:
No evidence of disease (32.8%)
Tumor regression (15.6%)
or Cancer stabilization (36.1%)
Importantly, adherence was remarkably high, with 86.9% completing the initial prescription and 66.4% remaining on therapy at six months.
Side effects were predominantly mild and manageable, reported in 25.4% of patients (primarily gastrointestinal), with 93.6% of those experiencing side effects continuing treatment after minor dosing adjustments.
This groundbreaking peer-reviewed publication was made possible through a unique collaboration between The Wellness Company, the McCullough Foundation, and the Chairman of the President’s Cancer Panel—uniting real-world clinical data, frontline medical experience, and epidemiologic expertise to evaluate inexpensive, repurposed therapies with major translational potential.
With these extraordinarily promising results, double-blind, placebo-controlled clinical trials are now required.
In the meantime, many cancer patients are exercising their right to try.
@twc_health@McCulloughFund@IIAR_Journals@P_McCulloughMD@DrHarveyRisch@DrKellyVictory@jathorpmfm@drdrew@PeterGillooly@FosterCoulson
Bill Gates proudly admits: the PEOPLE of India are his "LABORATORY" for testing experimental VACCINES and DRUGS.
This is WHY he is one of the most hated men on the planet.
We really never do see our personal realities with objectiveness. Things that are impressed upon us, words we read, things we hear... We receive those events through the lens of our own emotions, beliefs, experiences, even our personal level of consciousness.
In 1999, CDC data showed BABIES getting the Hep B vaccine in their first 30 days had a 1,135% INCREASE IN AUTISM compared to those who didn't get the vaccine.
They panicked, held a secret meeting at Simpsonwood with Big Pharma & regulators...then BURIED THE DATA.
And don't forget the age divide they constantly try to push through social media.
"This generation is better than that generation."
"Our generation had it harder than your generation."
"We were better parents than the parents of today."
And so on...
“Too often we enjoy the comfort of opinion without the discomfort of thought.”
— John F. Kennedy (Yale University commencement address, June 11, 1962).
So poignant given today's society.
#JFK